medspa semaglutide Certified Provider of for Weight Loss, Oxnard, Ventura County Wegovy/Semaglutide Weight Loss 10 Week
Description
Results: The mean change in body weight from baseline to week 68 was -14.9% in the semaglutide group as compared with -2.4% with placebo, for an estimated treatment difference of -12.4 percentage points (95% confidence interval [CI], -13.4 to -11.5
Jens Juul Holst, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark
The placebo group lost 2.4% body weight
Medication Access: If eligible after provider consultation, prescriptions can be filled at network pharmacies unless you specify otherwise
Not just obesity: GLP-1 receptor agonists advance on addiction
